Income Statement Olympus Corporation

Equities

7733

JP3201200007

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange Other stock markets 01:30:00 2026-02-06 am EST			5-day change	1st Jan Change
1,885.50 ^JPY	+1.43%		+2.42%	-4.99%

Jan. 28	Olympus Corporation Announces Executive Changes , Effective April 1, 2026	CI
Jan. 16	Olympus Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 02:15 PM

7f278ba8cad72e70.rzPpzUSwErV7MbqcCrGTJCN_trkrybNaGaGF56LW9p0.3mSgqiH9VI1IR-L5P4H8fVMb5-5EguE7UpXsreCet9zFfJ-1d-J00BFQjg

Published financial data: OLYMPUS CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	731B	869B	882B	936B	997B
Total Revenues	731B	869B	882B	936B	997B
Cost of Goods Sold, Total	271B	297B	285B	311B	314B
Gross Profit	460B	572B	597B	625B	684B
Selling General & Admin Expenses, Total	325B	371B	386B	438B	461B
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	31.54B	34.19B	34.15B	35.29B	34.41B
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	1.63B	-2.25B	4.22B	37.67B	20.62B
Other Operating Expenses, Total	359B	403B	425B	511B	516B
Operating Income	101B	169B	172B	114B	167B
Interest Expense, Total	-3.99B	-4.86B	-5.86B	-5.41B	-4.63B
Interest And Investment Income	1.17B	1.18B	3.74B	2.38B	3.31B
Net Interest Expenses	-2.82B	-3.68B	-2.12B	-3.03B	-1.32B
Income (Loss) On Equity Invest.	595M	1.49B	491M	-358M	466M
Currency Exchange Gains (Loss)	-2.1B	-158M	-2.14B	-4.49B	-2.02B
Other Non Operating Income (Expenses)	2.13B	-186M	-49M	-224M	-52M
EBT, Excl. Unusual Items	98.68B	166B	168B	106B	164B
Restructuring Charges	-23.64B	-18.73B	-2.36B	-5.85B	-2.86B
Gain (Loss) On Sale Of Investments	1.77B	2.83B	-	-	-
Gain (Loss) On Sale Of Assets	-	1.39B	16.4B	1.13B	-
Asset Writedown	-	-1.63B	-	-65.54B	-2.56B
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	76.81B	150B	182B	35.85B	159B
Income Tax Expense	11.14B	33.9B	44.3B	8.88B	41.27B
Earnings From Continuing Operations	65.67B	116B	138B	26.97B	118B
Earnings Of Discontinued Operations	-52.68B	-	5.62B	216B	55M
Net Income to Company	12.99B	116B	144B	243B	118B
Minority Interest	-71M	-228M	-181M	-363M	-
Net Income - (IS)	12.92B	116B	143B	243B	118B
Net Income to Common Incl Extra Items	12.92B	116B	143B	243B	118B
Net Income to Common Excl. Extra Items	65.6B	116B	138B	26.61B	118B
Per Share Items
Net EPS - Basic	10.05	90.22	113.22	199.91	102.99
Basic EPS - Continuing Operations	51.03	90.22	108.78	21.93	102.94
Basic Weighted Average Shares Outstanding	1.29B	1.28B	1.27B	1.21B	1.14B
Net EPS - Diluted	10.04	90.17	113.08	199.44	102.8
Diluted EPS - Continuing Operations	51	90.17	108.65	21.88	102.75
Diluted Weighted Average Shares Outstanding	1.29B	1.28B	1.27B	1.22B	1.15B
Normalized Basic EPS	47.92	80.7	82.87	54.36	89.84
Normalized Diluted EPS	47.89	80.66	82.77	54.23	89.68
Dividend Per Share	12	14	16	18	20
Payout Ratio	99.52	13.33	12.43	8.27	17.8
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	161B	233B	239B	180B	234B
EBITA	101B	169B	172B	114B	167B
EBIT	101B	169B	172B	114B	167B
Effective Tax Rate - (Ratio)	14.5	22.62	24.3	24.77	25.94
Normalized Net Income	61.6B	104B	105B	65.96B	103B
Non-Cash Pension Expense	19.06B	20.5B	19.27B	20.68B	21.13B
Supplemental Operating Expense Items
Advertising Expense	11.75B	15.17B	15.45B	16.19B	17.04B
Selling and Marketing Expenses	11.75B	15.17B	15.45B	16.19B	17.04B
Research And Development Expense From Footnotes	81.8B	85.3B	76.9B	86.4B	104B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	217B	303B	169B	341B	253B
Total Cash And Short Term Investments	217B	303B	169B	341B	253B
Accounts Receivable, Total	158B	178B	175B	198B	204B
Other Receivables	10.42B	3.72B	15.96B	36.69B	4.38B
Total Receivables	168B	182B	191B	234B	209B
Inventory	159B	167B	163B	190B	187B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	35.36B	42.52B	203B	35.09B	31.2B
Total Current Assets	580B	695B	726B	800B	679B
Net Property Plant And Equipment	239B	247B	239B	260B	263B
Long-term Investments	75.15B	73.64B	88.99B	129B	150B
Goodwill	131B	164B	183B	180B	180B
Other Intangibles, Total	100B	120B	115B	91.96B	93.97B
Deferred Tax Assets Long-Term	55.51B	57.78B	157B	72.32B	65.4B
Total Assets	1,181B	1,358B	1,508B	1,534B	1,433B
Liabilities
Accounts Payable, Total	69.89B	60.55B	62.92B	61.86B	61.42B
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	5.46B	67M	3M	-	-
Current Portion of Long-Term Debt	26.07B	52.21B	49.97B	69.99B	94.98B
Current Portion of Leases	-	-	-	-	-
Current Income Taxes Payable	10.74B	34.35B	99.57B	38.66B	42.45B
Other Current Liabilities	216B	229B	206B	261B	227B
Total Current Liabilities	328B	376B	419B	432B	425B
Long-Term Debt	324B	334B	290B	230B	134B
Long-Term Leases	-	-	-	-	-
Pension & Other Post Retirement Benefits	42.45B	40B	20.42B	20.59B	19.8B
Deferred Tax Liability Non Current	10.85B	13.09B	11.9B	11.99B	13.63B
Other Non Current Liabilities	80.11B	83.45B	126B	83.13B	88.18B
Total Liabilities	786B	847B	867B	777B	681B
Common Stock, Total	125B	125B	125B	125B	125B
Additional Paid In Capital	90.84B	91.24B	92.15B	92.03B	92.43B
Retained Earnings	278B	305B	371B	493B	421B
Treasury Stock	-98.05B	-45.59B	-28.09B	-102B	-27.92B
Comprehensive Income and Other	-1.35B	34.82B	80.31B	149B	142B
Total Common Equity	394B	510B	640B	757B	752B
Minority Interest	1.15B	1.19B	1.15B	-	-
Total Equity	395B	511B	641B	757B	752B
Total Liabilities And Equity	1,181B	1,358B	1,508B	1,534B	1,433B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.29B	1.27B	1.25B	1.17B	1.13B
ECS Total Common Shares Outstanding	1.29B	1.27B	1.25B	1.17B	1.13B
Book Value / Share	306.72	400.75	510.62	649.59	666.54
Tangible Book Value	163B	225B	342B	485B	478B
Tangible Book Value Per Share	126.85	176.99	273.14	415.99	423.45
Total Debt	355B	386B	340B	300B	229B
Net Debt	138B	83.56B	171B	-41.32B	-23.43B
Debt Equivalent of Unfunded Proj. Benefit Obligation	19.77B	14.03B	-6.61B	-16.23B	-20.71B
Minority Interest, Total (Incl. Fin. Div)	1.15B	1.19B	1.15B	-	-
Equity Method Investments, Total	3.13B	1.51B	1.01B	479M	482M
Inventories - Raw Materials, Total	57.37B	62.82B	62.89B	74.97B	81.1B
Inventories - Work In Process, Total	23.72B	40.43B	33.53B	47.76B	28.24B
Inventories - Finished Goods, Total	77.9B	64.12B	66.58B	67.29B	77.81B
Full Time Employees	31.65K	31.56K	32.84K	28.84K	29.3K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	76.81B	150B	182B	35.85B	159B
Depreciation & Amortization - CF	59.94B	64.62B	66.74B	65.94B	66.46B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	59.94B	64.62B	66.74B	65.94B	66.46B
(Gain) Loss From Sale Of Asset	842M	3.4B	-13.26B	65.02B	3.64B
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-595M	-1.49B	-491M	358M	-466M
Net Cash From Discontinued Operations	-52.48B	-	7.41B	348B	61M
Other Operating Activities, Total	-25.82B	-8.58B	-96.92B	-137B	3.44B
Change In Accounts Receivable	-9.72B	-10.98B	-27.01B	-11.85B	-27.72B
Change In Inventories	4.02B	-2.1B	-26.85B	-19.07B	-3.41B
Change In Accounts Payable	7.36B	-8.83B	8.77B	-5.94B	-1.93B
Change in Other Net Operating Assets	63.76B	-16.17B	-2.2B	-299B	-8.68B
Cash from Operations	124B	170B	98.49B	42.36B	190B
Capital Expenditure	-38.66B	-41.69B	-47.57B	-46.42B	-46B
Sale of Property, Plant, and Equipment	1.62B	4.48B	20.46B	1.47B	-
Cash Acquisitions	-45.61B	-21.84B	-3.86B	-	-3.88B
Divestitures	1.33B	724M	-	4.47B	-
Sale (Purchase) of Intangible assets	-20.57B	-20.08B	-23.05B	-18.2B	-19.21B
Investment in Marketable and Equity Securities, Total	7.88B	8.28B	-4.91B	-28M	-8.59B
Net (Increase) Decrease in Loans Originated / Sold - Investing	701M	1.14B	-	53.37B	4.28B
Other Investing Activities, Total	-25.61B	-2.04B	516M	365B	7.93B
Cash from Investing	-119B	-71.02B	-58.41B	360B	-65.47B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	149B	56.14B	-	-	-
Total Debt Issued	149B	56.14B	-	-	-
Short Term Debt Repaid, Total	-67.72B	-5.45B	-67M	-3M	-
Long-Term Debt Repaid, Total	-10.61B	-26.25B	-53.55B	-50B	-70.04B
Total Debt Repaid	-78.33B	-31.7B	-53.61B	-50B	-70.04B
Repurchase of Common Stock	-2M	-30B	-50B	-180B	-100B
Common Dividends Paid	-12.86B	-15.43B	-17.82B	-20.06B	-20.98B
Common & Preferred Stock Dividends Paid	-12.86B	-15.43B	-17.82B	-20.06B	-20.98B
Other Financing Activities, Total	-17B	-19.68B	-21.74B	-25.95B	-20.52B
Cash from Financing	40.8B	-40.67B	-143B	-276B	-212B
Foreign Exchange Rate Adjustments	8.76B	27.05B	6.04B	9.07B	-1.85B
Net Change in Cash	54.76B	85.09B	-97.06B	135B	-88.4B
Supplemental Items
Cash Interest Paid	3.36B	4.29B	5.39B	4.8B	4.19B
Cash Income Tax Paid (Refund)	26.46B	9.16B	97.57B	137B	-3.01B
Levered Free Cash Flow	91.12B	103B	-20.29B	160B	104B
Unlevered Free Cash Flow	93.62B	106B	-16.63B	163B	107B
Change In Net Working Capital	-29.86B	2.24B	120B	-90.66B	-1.16B
Net Debt Issued / Repaid	70.66B	24.44B	-53.61B	-50B	-70.04B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.74	8.3	7.5	4.69	7.05
Return on Total Capital	8.98	12.78	11.45	7.01	10.27
Return On Equity %	17.11	25.58	23.94	3.86	15.61
Return on Common Equity	17.15	25.59	23.96	3.81	15.61
Margin Analysis
Gross Profit Margin %	62.9	65.8	67.68	66.77	68.55
SG&A Margin	44.55	42.72	43.81	46.78	46.25
EBITDA Margin %	22.01	26.84	27.08	19.24	23.45
EBITA Margin %	13.81	19.4	19.51	12.2	16.79
EBIT Margin %	13.81	19.4	19.51	12.2	16.79
Income From Continuing Operations Margin %	8.99	13.35	15.65	2.88	11.81
Net Income Margin %	1.77	13.32	16.26	25.91	11.82
Net Avail. For Common Margin %	8.98	13.32	15.63	2.84	11.81
Normalized Net Income Margin	8.43	11.92	11.9	7.05	10.31
Levered Free Cash Flow Margin	12.47	11.84	-2.3	17.09	10.44
Unlevered Free Cash Flow Margin	12.81	12.19	-1.89	17.45	10.73
Asset Turnover
Asset Turnover	0.67	0.68	0.62	0.62	0.67
Fixed Assets Turnover	3.31	3.58	3.63	3.75	3.81
Receivables Turnover (Average Receivables)	4.85	5.17	5	5.03	4.96
Inventory Turnover (Average Inventory)	1.66	1.82	1.73	1.76	1.66
Short Term Liquidity
Current Ratio	1.77	1.85	1.74	1.85	1.6
Quick Ratio	1.17	1.29	0.86	1.33	1.08
Operating Cash Flow to Current Liabilities	0.38	0.45	0.24	0.1	0.45
Days Sales Outstanding (Average Receivables)	75.19	70.65	73.07	72.77	73.52
Days Outstanding Inventory (Average Inventory)	219.92	200.42	211.49	207.67	219.47
Average Days Payable Outstanding	90.03	77.91	80.27	67.53	72.39
Cash Conversion Cycle (Average Days)	205.08	193.16	204.29	212.91	220.6
Long Term Solvency
Total Debt/Equity	89.83	75.51	53.03	39.57	30.48
Total Debt / Total Capital	47.32	43.02	34.65	28.35	23.36
LT Debt/Equity	81.86	65.29	45.24	30.33	17.84
Long-Term Debt / Total Capital	43.12	37.2	29.56	21.73	13.67
Total Liabilities / Total Assets	66.51	62.34	57.49	50.65	47.53
EBIT / Interest Expense	25.29	34.65	29.34	21.12	36.18
EBITDA / Interest Expense	40.32	47.93	40.72	33.31	50.55
(EBITDA - Capex) / Interest Expense	30.63	39.36	32.61	24.72	40.6
Total Debt / EBITDA	2.21	1.66	1.42	1.66	0.98
Net Debt / EBITDA	0.86	0.36	0.71	-0.23	-0.1
Total Debt / (EBITDA - Capex)	2.91	2.02	1.78	2.24	1.22
Net Debt / (EBITDA - Capex)	1.13	0.44	0.89	-0.31	-0.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-8.39	18.93	1.5	6.16	6.53
Gross Profit, 1 Yr. Growth %	-8.01	24.41	4.4	4.74	9.37
EBITDA, 1 Yr. Growth %	1.59	45	2.43	-24.56	29.81
EBITA, 1 Yr. Growth %	12.1	67.1	2.1	-33.62	46.57
EBIT, 1 Yr. Growth %	12.1	67.1	2.1	-33.62	46.57
Earnings From Cont. Operations, 1 Yr. Growth %	27.13	76.6	18.99	-80.45	336.73
Net Income, 1 Yr. Growth %	-75	795.97	23.92	69.12	-51.41
Normalized Net Income, 1 Yr. Growth %	16.21	68.07	1.4	-37.17	55.86
Diluted EPS Before Extra, 1 Yr. Growth %	29.57	76.8	20.49	-79.86	369.61
Accounts Receivable, 1 Yr. Growth %	10.39	12.99	-2.11	13.13	3.33
Inventory, 1 Yr. Growth %	-5.14	5.27	-2.61	16.59	-1.52
Net Property, Plant and Equip., 1 Yr. Growth %	18.21	3.41	-3.39	8.9	1.32
Total Assets, 1 Yr. Growth %	16.28	14.99	11.07	1.72	-6.61
Tangible Book Value, 1 Yr. Growth %	-17.48	38.16	51.97	41.62	-1.51
Common Equity, 1 Yr. Growth %	6.36	29.38	25.47	18.29	-0.72
Cash From Operations, 1 Yr. Growth %	-7.06	36.74	-41.97	-56.99	349.58
Capital Expenditures, 1 Yr. Growth %	2.35	7.83	14.11	-2.41	-0.91
Levered Free Cash Flow, 1 Yr. Growth %	10.85	12.93	-119.72	-888.44	-34.9
Unlevered Free Cash Flow, 1 Yr. Growth %	10.67	13.17	-115.69	-1.08K	-34.47
Dividend Per Share, 1 Yr. Growth %	20	16.67	14.29	12.5	11.11
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-4.07	4.38	9.87	3.8	6.34
Gross Profit, 2 Yr. CAGR %	-5.04	6.98	13.97	4.57	7.03
EBITDA, 2 Yr. CAGR %	16.16	21.37	21.87	-12.1	-1.04
EBITA, 2 Yr. CAGR %	29.11	36.87	30.62	-17.68	-1.36
EBIT, 2 Yr. CAGR %	29.11	36.87	30.62	-17.68	-1.36
Earnings From Cont. Operations, 2 Yr. CAGR %	185.64	49.84	44.96	-51.77	-7.6
Net Income, 2 Yr. CAGR %	25.92	49.67	233.22	44.77	-9.35
Normalized Net Income, 2 Yr. CAGR %	36.24	39.75	30.55	-20.18	-1.04
Diluted EPS Before Extra, 2 Yr. CAGR %	192.52	51.36	45.96	-50.74	-2.75
Accounts Receivable, 2 Yr. CAGR %	0.83	11.68	5.17	5.24	8.12
Inventory, 2 Yr. CAGR %	1.73	-0.07	1.25	6.56	7.15
Net Property, Plant and Equip., 2 Yr. CAGR %	16.22	10.57	-0.05	2.57	5.04
Total Assets, 2 Yr. CAGR %	12.57	15.63	13.01	6.29	-2.53
Tangible Book Value, 2 Yr. CAGR %	-22.39	6.77	44.9	46.7	18.1
Common Equity, 2 Yr. CAGR %	-5.46	17.31	27.41	21.83	8.37
Cash From Operations, 2 Yr. CAGR %	36.17	12.74	-10.92	-50.04	39.06
Capital Expenditures, 2 Yr. CAGR %	-9.4	5.05	10.93	5.53	-1.66
Levered Free Cash Flow, 2 Yr. CAGR %	115.58	11.88	-52.81	24.69	126.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	104.01	11.91	-57.86	24.18	153.75
Dividend Per Share, 2 Yr. CAGR %	26.49	18.32	15.47	13.39	11.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-2.43	3.06	3.41	8.62	4.7
Gross Profit, 3 Yr. CAGR %	-3.44	3.91	6.11	10.8	6.14
EBITDA, 3 Yr. CAGR %	6.63	25.07	14.7	3.86	0.1
EBITA, 3 Yr. CAGR %	8.16	40.7	24.13	4.23	-0.22
EBIT, 3 Yr. CAGR %	8.16	40.7	24.13	4.23	-0.22
Earnings From Cont. Operations, 3 Yr. CAGR %	4.78	143.33	38.75	-25.67	0.52
Net Income, 3 Yr. CAGR %	-39.05	142.19	40.54	165.79	0.6
Normalized Net Income, 3 Yr. CAGR %	9.41	46.11	25.58	2.31	-0.23
Diluted EPS Before Extra, 3 Yr. CAGR %	6.95	147.33	40.28	-24.58	4.45
Accounts Receivable, 3 Yr. CAGR %	0.12	4.73	6.88	7.76	4.6
Inventory, 3 Yr. CAGR %	4.5	2.9	-0.92	6.13	3.79
Net Property, Plant and Equip., 3 Yr. CAGR %	12.41	11.78	5.7	2.85	2.15
Total Assets, 3 Yr. CAGR %	6.47	13.37	14.09	9.11	1.8
Tangible Book Value, 3 Yr. CAGR %	-15.7	-5.94	20.1	43.8	28.46
Common Equity, 3 Yr. CAGR %	-3.79	4.96	19.96	24.29	13.79
Cash From Operations, 3 Yr. CAGR %	9.27	36.36	-9.65	-30.11	3.92
Capital Expenditures, 3 Yr. CAGR %	-7.51	-3.98	7.99	6.29	3.34
Levered Free Cash Flow, 3 Yr. CAGR %	7.32	73.78	-37.27	20.64	0.4
Unlevered Free Cash Flow, 3 Yr. CAGR %	6.32	67.63	-41.86	20.39	0.35
Dividend Per Share, 3 Yr. CAGR %	19.68	23.13	16.96	14.47	12.62
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.91	3.04	2.32	3.35	4.58
Gross Profit, 5 Yr. CAGR %	-3	3.08	3.18	4.17	6.48
EBITDA, 5 Yr. CAGR %	0.84	12.43	12.48	8.62	8.12
EBITA, 5 Yr. CAGR %	-2.47	14.64	16.64	13.55	13.22
EBIT, 5 Yr. CAGR %	-0.7	17.12	16.64	13.55	13.22
Earnings From Cont. Operations, 5 Yr. CAGR %	0.95	8.2	19.3	27.36	17.93
Net Income, 5 Yr. CAGR %	-27.07	8.16	20.24	97.14	17.93
Normalized Net Income, 5 Yr. CAGR %	1.65	21.68	17.42	14.72	14.17
Diluted EPS Before Extra, 5 Yr. CAGR %	2.21	9.57	21.12	29.71	21.16
Accounts Receivable, 5 Yr. CAGR %	-1.19	1.27	2.11	4.93	7.37
Inventory, 5 Yr. CAGR %	7.34	6.17	3.19	4.35	2.23
Net Property, Plant and Equip., 5 Yr. CAGR %	7.55	7.6	7.25	8	5.44
Total Assets, 5 Yr. CAGR %	3.37	6.5	9.04	10.48	7.12
Tangible Book Value, 5 Yr. CAGR %	-6.81	-5.46	4.69	12.36	19.3
Common Equity, 5 Yr. CAGR %	0.6	3.51	7.65	11.41	15.19
Cash From Operations, 5 Yr. CAGR %	20.62	13.48	0.69	-8.74	7.36
Capital Expenditures, 5 Yr. CAGR %	-5.17	-0.87	-0.53	-0.29	4.02
Levered Free Cash Flow, 5 Yr. CAGR %	91.34	17.69	-22.74	52.17	4.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	61.63	16.05	-26.57	48.67	4.82
Dividend Per Share, 5 Yr. CAGR %	23.07	14.87	17.98	19.14	14.87